Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles

BACKGROUND: Infections with influenza A virus (IAV) cause high morbidity and mortality in humans. Additional to vaccination, antiviral drugs are a treatment option. Besides FDA-approved drugs such as oseltamivir or zanamivir, virus-derived defective interfering (DI) particles (DIPs) are considered p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Marc D., Arora, Prerna, Marichal-Gallardo, Pavel, Winkler, Michael, Genzel, Yvonne, Pöhlmann, Stefan, Schughart, Klaus, Kupke, Sascha Y., Reichl, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091782/
https://www.ncbi.nlm.nih.gov/pubmed/33941189
http://dx.doi.org/10.1186/s12915-021-01020-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091782/
https://www.ncbi.nlm.nih.gov/pubmed/33941189
http://dx.doi.org/10.1186/s12915-021-01020-5

Ejemplares similares